martes, 22 de agosto de 2017

HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. | National Guideline Clearinghouse

<em>HER2</em> testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. | National Guideline Clearinghouse

ngc

American Society of Clinical Oncology


  • GUIDELINE SUMMARY
  •  
  • NGC:011197
  •  
  • 2017 FEB 1

HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

No hay comentarios:

Publicar un comentario